Adrenocortical carcinoma: Clinical presentation, outcomes of treatment and survival analysis from a 15-year experience

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220614002

Enrollment

Registered

2022-06-14

Start date

2021-11-12

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACC patients who underwent surgical extirpation. Adrenocortical carcinoma, Surgery, Chemotherapy, Mitotane, Survival, Prognosis

Interventions

ACC patients who underwent surgical extirpation

Treatment

Adrenocorticol carcinoma

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: ACC patients who underwent surgical extirpation in King Chulalongkorn Memorial Hospital between January 2005 and December 2020.

Exclusion criteria

Exclusion criteria: Age under 18-year-old

Design outcomes

Primary

Measure	Time frame
Overall survival at 12, 24, 60 months Kaplan-Meier Curve	—

Secondary

Measure	Time frame
Prognostic factors none Cox-regression analysis	—

Countries

Thailand

Contacts

Public ContactKamol panumatrassamee

King Chulalongkorn Memorial Hospital

kamol_uro@hotmail.com0817502988

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026